Showing results (121-130 of 354) with videos related to
Sort By:
Pageof 36
STAR Protocols|November 2, 2024
Protocol to study human gut bacterial communities and rhythmicity ex vivo using a chemostat systemHelena Heimes, Deborah Häcker, Hélène Omer, et al.Microbiology and Immunology|May 15, 2002
IL-10 producing CD14low monocytes inhibit lymphocyte-dependent activation of intestinal epithelial cells by commensal bacteriaDirk Haller, Patrik Serrant, Genneviève Peruisseau, et al.BMC Medical Informatics and Decision Making|June 7, 2017
CMOST: an open-source framework for the microsimulation of colorectal cancer screening strategiesMeher K Prakash, Brian Lang, Henriette Heinrich, et al.BMC Bioinformatics|January 16, 2010
Enhanced CellClassifier: a multi-class classification tool for microscopy imagesBenjamin Misselwitz, Gerhard Strittmatter, Balamurugan Periaswamy, et al.Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 26, 2020
Improved treatment outcome and lower skin toxicity with intensity-modulated radiotherapy vs. 3D conventional radiotherapy in anal cancerMatthias Sauter, Norbert Lombriser, Simon Bütikofer, et al.Praxis|September 19, 2019
[From Axial Spondyloarthritis to Osteoporosis - Spectrum of Skeletal Involvement in Inflammatory Bowel Diseases]Solvey Schüle, Diana Frey, Luc Biedermann, et al.British Journal of Pharmacology|November 4, 2020
The oxysterol receptor GPR183 in inflammatory bowel diseasesBenjamin Misselwitz, Annika Wyss, Tina Raselli, et al.Molecular Nutrition & Food Research|May 2, 2015
Physiological relevance of food grade microcapsules: Impact of milk protein based microcapsules on inflammation in mouse models for inflammatory bowel diseasesRebecca Würth, Ilias Lagkouvardos, Thomas Clavel, et al.Journal of Agricultural and Food Chemistry|July 3, 2019
Milk-Derived Amadori Products in Feces of Formula-Fed InfantsNina Sillner, Alesia Walker, Daniel Hemmler, et al.Protein Engineering, Design & Selection : PEDS|June 12, 2013
PASylation: a biological alternative to PEGylation for extending the plasma half-life of pharmaceutically active proteinsMartin Schlapschy, Uli Binder, Claudia Börger, et al.Pageof 36